A previous study (26) found that FOXP3 mRNA expression was significantly reduced in the PBMCs from HT patients, while the number of peripheral blood Th17s and IL-17 mRNA expression in HT thyroid tissues were increased. The gene discussed is FOXP3; the disease is hematocrit.